Anti-TNF Therapeutic Drug Monitoring in Postoperative Crohn's Disease

Emily K Wright; Michael A Kamm; Peter De Cruz; Amy L Hamilton; Fabiyola Selvaraj; Fred Princen; Alexandra Gorelik; Danny Liew; Lani Prideaux; Ian C Lawrance; Jane M Andrews; Peter A Bampton; Simon L Jakobovits; Timothy H Florin; Peter R Gibson; Henry Debinski; Finlay A Macrae; Douglas Samuel; Ian Kronborg; Graham Radford-Smith; Richard B Gearry; Warwick Selby; Sally J Bell; Steven J Brown; William R Connell

Journal article

Anti-TNF Therapeutic Drug Monitoring in Postoperative Crohn's Disease

Emily K Wright, Michael A Kamm, Peter De Cruz, Amy L Hamilton, Fabiyola Selvaraj, Fred Princen, Alexandra Gorelik, Danny Liew, Lani Prideaux, Ian C Lawrance, Jane M Andrews, Peter A Bampton, Simon L Jakobovits, Timothy H Florin, Peter R Gibson, Henry Debinski, Finlay A Macrae, Douglas Samuel, Ian Kronborg, Graham Radford-Smith Show all

Journal of Crohn's and Colitis | OXFORD UNIV PRESS | Published : 2018

DOI: 10.1093/ecco-jcc/jjy003

University of Melbourne Researchers

Alex Gorelik Author Medicine - Royal Melbourne Hospital

Michael Kamm Author Medicine - St Vincent's Hospital

Ian Kronborg Author

Danny Liew Author Medicine - Royal Melbourne Hospital

Sally Bell Author Medical Education

Grants

Funding Acknowledgements

Prometheus Laboratories [San Diego, CA, USA] undertook all drug concentration analyses. AbbVie, Gutsy Group, Gandel Philanthropy, Angior Foundation and Crohn's Colitis Australia provided funding for the conduct of the POCER study. The National Health and Medical Research Council [NHMRC] supported EKW, PDC and MAK. St Vincent's Research Foundation supported MAK.